More redundancies are planned at BenevolentAI while the BioTech firm’s restructure is also expected to see it delist from the Euronext exchange in Amsterdam. Founder Kenneth Mulvany, who led a boardroom coup earlier this year and subsequently helped to narrow losses at the MedTech before returning to the helm as executive chairman, outlined plans to … Continue reading More layoffs as BenevolentAI plans to delist & return to ‘original mission’